Canada: Passage Of Vanessa’s Law Brings About Increased Health Canada Oversight And Powers Over Therapeutic Products

Last Updated: November 26 2014
Article by Emily Larose

Canada's Food and Drugs Act ("the Act") was first enacted in 1920 and has been amended many times over the years. On November 6, 2014, Bill C-17 (also referred to as the Protecting Canadians from Unsafe Drugs Act or Vanessa's Law) received Royal Assent and was enacted into law. This brings about the most significant set of amendments to the Act in decades. These amendments focus primarily on safety of "therapeutic products" (a new definition which includes drugs and medical devices, but not natural health products) once they are approved and on the market. Although much of the detail of the implementation of these changes has been left to as-yet unpublished Regulations, there is no question that the amendments reflect a significant increase in Ministerial oversight and powers.

Key amendments include the following:

1.    New Ministerial Powers – the amendments grant the authority for the Minister of Health ("the Minister") to issue a large number of orders, including:

a.     Orders for the provision of information

b.    Orders requiring labelling and packaging modifications

c.     Orders that products be sent to a particular place

d.    Orders for recalls, product assessments and other corrective action

e.    Orders requiring information to be compiled and tests, studies or monitoring to be conducted

The basis for the issuance of the above orders differs depending on which order the Minister wishes to make. For example, the Minister may issue an order for the provision of information on the basis of a belief that a product presents a serious risk of injury to human health. In the case of recall orders, the risk of injury to health may be serious or imminent. 

The amendments also provide for the Minister to apply to the court for injunctions.

2.    Incident Reporting By Institutions – the amendments provide for mandatory incident reporting by as-yet undefined "institutions." Although it is expected that this will expand mandatory incident reporting to hospitals and possibly other health care facilities, the scope and procedure for such reports is to be further expanded upon in Regulations.

3.    Confidential Business Information ("CBI") – as has been seen in other recently enacted product safety legislation, the amendments provide for scenarios in which the Minister may disclose otherwise confidential business information without consent. However, in this case, the threshold for such disclosure is arguably significantly lower: allowing that CBI can be disclosed without notice or consent if the purpose of the disclosure is related to the protection or promotion of human health or the safety of the public if the disclosure is to one of a list of entities and people. Unlike other product safety legislation, there is also no post-disclosure notification requirement.

4.    Increased Penalties – the amendments bring into force much more significant penalties (for companies as well as their directors, officers and certain other representatives) for offences.  Previously, the harshest penalties for non-food related offences were fines of $5,000 and three years in prison. Pursuant to the amendments, contravention of the Act or its Regulations in respect of a therapeutic product can result in fines of up to $5 million and imprisonment for two years.  For providing false information or for knowingly or recklessly causing a serious risk of injury to human health in the contravention of the Act or Regulations, the penalties include an unlimited fine and imprisonment for up to five years.

The impact of these penalties is exacerbated by the fact that each day on which an offence is carried out constitutes a separate offence.

5.    New Regulation-Making Powers – the amendments permit the making of Regulations relating to a number of post-marketing activities including the issuance of therapeutic product authorizations, permitting conditions to be placed on authorizations, relating to clinical trial and investigational test information, regarding foreign activity and requiring modifications to labels.


The impact of the new Ministerial powers will not be truly appreciated until Regulations are released and we have an opportunity to see how Health Canada will be applying its new powers. However, there are some issues to consider even at this early stage.

Industry should take these legislative changes as an opportunity to review compliance programs and standard operating policies to ensure that they reflect the new regulatory environment under the amended Act. In light of the prospect of greater scrutiny and enhanced Ministerial powers, companies' training on, and implementation of, these programs and policies should also be revisited. The Act provides a due diligence defence against prosecution, so the importance of being able to provide evidence of a corporate culture of compliance is further underscored.

In light of the increased possibility of disclosure of otherwise confidential business information, communications protocols should be considered. These amendments underscore the importance of ensuring that information provided to Health Canada is accurately and carefully worded to reduce the risk of documents being taken out of context and ensuring that communications strategies are coordinated across jurisdictions. 

The potential impact of this amended legislation on product liability exposure is unknown and will very much depend on the manner in which it is implemented. If the amendments bring about more mandatory product recalls, prosecutions and increased disclosure of otherwise confidential information, it is certainly possible that product liability claims may increase accordingly. In Canada, such claims are often the subject of proposed class actions.

We will continue to follow the implementation of Vanessa's Law and provide updates as Regulations are released. If you have any questions, please feel free to contact the author of this e-LERT. 

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Emily Larose
In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.